Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02288611 | The Impact of Palm Date Intake on Colon Health Biomarkers(AJWA) | completed | N/A | 22 | University of ReadingOTHER | 0 | Nov 11, 2014 | clinicaltrials |
| NCT01554059 | Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients(New Beat) | completed | Phase 2 | 25 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Nov 10, 2014 |
| clinicaltrials |
| NCT01158274 | RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 2 | Nov 7, 2014 | clinicaltrials |
| NCT00879385 | KRAS Wild-type Metastatic Colorectal Cancer Trial | completed | Phase 1 | 21 | University of UtahOTHER | 1 | Oct 31, 2014 | clinicaltrials |
| NCT00004210 | Study of the Results of Education and Counseling for Persons Undergoing Genetic Testing for Hereditary Nonpolyposis Colon Cancer | completed | N/A | 900 | National Human Genome Research Institute (NHGRI)NIH | 1 | Oct 24, 2014 | clinicaltrials |
| NCT01811108 | Assessment of Clinical Practice Administration of Chemotherapy and Anti-angiogenic Agent (Bevacizumab) in Colorectal Cancer | completed | — | 670 | Hellenic Oncology Research GroupOTHER | 1 | Oct 24, 2014 | clinicaltrials |
| NCT01378143 | Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard Chemotherapy | completed | Phase 2 | 53 | Oncozyme Pharma Inc.INDUSTRY | 1 | Oct 21, 2014 | clinicaltrials |
| NCT01801059 | Patient Activation Intervention in Improving Screening Rates for Colorectal Cancer | completed | N/A | 284 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Oct 16, 2014 | clinicaltrials |
| NCT01595256 | Exploration the Effect of Walking Program in Patients With Colorectal Cancer | completed | N/A | 237 | National Taiwan University HospitalOTHER | 1 | Oct 15, 2014 | clinicaltrials |
| NCT02032485 | Near-Infrared Imaging of Peritoneal Carcinomatosis From Colorectal Cancer(OC-AP-ICG-IV) | completed | Phase 2 | 10 | Jules Bordet InstituteOTHER | 1 | Oct 15, 2014 | clinicaltrials |
| NCT01286818 | A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B) | completed | Phase 1 | 6 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 6, 2014 | clinicaltrials |
| NCT01372527 | Population-Based Patient-Centric Care: Comprehensive Preventive Cancer Screening Using Health IT(TopCare) | completed | N/A | 103,870 | Massachusetts General HospitalOTHER | 1 | Oct 3, 2014 | clinicaltrials |
| NCT00905918 | Vitamin E Supplements in Treating Patients Undergoing Surgery for Colorectal Cancer | completed | Phase 1 | 14 | Rutgers, The State University of New JerseyOTHER | 1 | Sep 30, 2014 | clinicaltrials |
| NCT02250196 | A Randomized Prospective Trial Comparing Low-volume Bowel Preparation Methods | completed | Phase 3 | 200 | Korea University Anam HospitalOTHER | 1 | Sep 26, 2014 | clinicaltrials |
| NCT00898378 | Study of Biomarkers in Blood & Tissue Samples From Patients With Colorectal Cancer or Polyps & Patients Without Polyps | completed | — | 551 | Indiana UniversityOTHER | 1 | Sep 18, 2014 | clinicaltrials |
| NCT01405183 | Association Between Hepatitis C Infection and Renal Cell Carcinoma | completed | — | 240 | Henry Ford Health SystemOTHER | 1 | Sep 17, 2014 | clinicaltrials |
| NCT00433576 | Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Sep 15, 2014 | clinicaltrials |
| NCT00507598 | Metabolomics-Based Detection of Colorectal Cancer(metabolomics) | completed | — | 69 | Indiana UniversityOTHER | 1 | Sep 11, 2014 | clinicaltrials |
| NCT01525056 | Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Nodes Using Pet-Ct, CT-Perfusion and 3T MRI | completed | Phase 2 | 30 | London Health Sciences CentreOTHER | 1 | Sep 9, 2014 | clinicaltrials |
| NCT00027534 | Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 14 | Michael Morse, MDOTHER | 1 | Sep 8, 2014 | clinicaltrials |
| NCT00450424 | Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer | completed | N/A | 239 | Fox Chase Cancer CenterOTHER | 1 | Sep 5, 2014 | clinicaltrials |
| NCT01186263 | Predictive Value of 99mTc- Albumin Spheres Before 90Y- SIR Therapy(EXPLOSIVE) | completed | Phase 2 | 24 | University of MagdeburgOTHER | 1 | Sep 4, 2014 | clinicaltrials |
| NCT00416494 | Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer | completed | Phase 2 | 50 | Herbert Hurwitz, MDOTHER | 0 | Sep 3, 2014 | clinicaltrials |
| NCT01159171 | A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer. | completed | Phase 2 | 50 | Hoffmann-La RocheINDUSTRY | 1 | Aug 15, 2014 | clinicaltrials |
| NCT00514761 | Phase II Efficacy Study of AZD6244 in Colorectal Cancer | completed | Phase 2 | 64 | AstraZenecaINDUSTRY | 1 | Aug 13, 2014 | clinicaltrials |
| NCT00623805 | A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 123 | Hoffmann-La RocheINDUSTRY | 1 | Aug 8, 2014 | clinicaltrials |
| NCT00125034 | Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)(OPUS) | completed | Phase 2 | 344 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 13 | Aug 7, 2014 | clinicaltrials |
| NCT00855348 | PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening(PRESEPT) | completed | — | 7,929 | Epigenomics, IncINDUSTRY | 2 | Aug 4, 2014 | clinicaltrials |
| NCT01329718 | Specimens for Septin 9 Performance(SPR0012) | completed | Early Phase 1 | 562 | Epigenomics, IncINDUSTRY | 0 | Aug 4, 2014 | clinicaltrials |
| NCT01105377 | Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 47 | National Cancer Institute (NCI)NIH | 1 | Aug 1, 2014 | clinicaltrials |
| NCT01954862 | Comparison of Methods to Distend the Colon During Insertion: CO2, Air Insufflation, Water-aided Colonoscopy | completed | N/A | 624 | Presidio Ospedaliero Santa BarbaraOTHER | 3 | Jul 31, 2014 | clinicaltrials |
| NCT00159432 | Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer | completed | Phase 2 | 63 | University of Southern CaliforniaOTHER | 1 | Jul 29, 2014 | clinicaltrials |
| NCT01181609 | A Study of Avastin (Bevacizumab) Combined With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum | completed | Phase 2 | 54 | Hoffmann-La RocheINDUSTRY | 1 | Jul 28, 2014 | clinicaltrials |
| NCT00856115 | Differences in Timely Cancer Diagnosis in African American and Caucasian Patients With Newly Diagnosed Colorectal Cancer | completed | — | 84 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 16, 2014 | clinicaltrials |
| NCT00393822 | A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer | completed | Phase 2 / Phase 3 | 100 | AmgenINDUSTRY | 0 | Jul 15, 2014 | clinicaltrials |
| NCT00044343 | GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin | completed | Phase 2 | 80 | GlaxoSmithKlineINDUSTRY | 2 | Jul 10, 2014 | clinicaltrials |
| NCT01205711 | Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer(FOLFERA) | completed | Phase 2 | 111 | Cardiff UniversityOTHER | 1 | Jul 8, 2014 | clinicaltrials |
| NCT02181465 | Study to Assess Safety and Tolerability of G17DT in Patients With Colorectal Adenocarcinoma.(CC1A&B) | completed | Phase 2 | 11 | Cancer Advances Inc.INDUSTRY | 1 | Jul 4, 2014 | clinicaltrials |
| NCT00165854 | Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 46 | Eisai LimitedINDUSTRY | 3 | Jun 27, 2014 | clinicaltrials |
| NCT00439517 | Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.(FUTURE) | completed | Phase 2 | 302 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 14 | Jun 27, 2014 | clinicaltrials |
| NCT00942266 | Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment | completed | Phase 2 | 58 | Roswell Park Cancer InstituteOTHER | 1 | Jun 23, 2014 | clinicaltrials |
| NCT00256334 | Resveratrol for Patients With Colon Cancer | completed | Phase 1 | 11 | University of California, IrvineOTHER | 1 | Jun 20, 2014 | clinicaltrials |
| NCT01208194 | Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma(IMPACT) | completed | Phase 2 | 59 | Mologen AGINDUSTRY | 6 | Jun 20, 2014 | clinicaltrials |
| NCT01175317 | Improvement of Fluid Balance in Patients Undergoing Surgery of the Colon and Rectum(HOC) | completed | Phase 4 | 58 | Maastricht University Medical CenterOTHER | 1 | Jun 19, 2014 | clinicaltrials |
| NCT00862784 | A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer | completed | Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 2 | Jun 17, 2014 | clinicaltrials |
| NCT01163552 | Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity | completed | Phase 2 | 5 | St. Luke's-Roosevelt Hospital CenterOTHER | 1 | Jun 13, 2014 | clinicaltrials |
| NCT01005225 | Genetic Investigation of Solid Tumors Cohort | completed | — | 25 | Scripps Translational Science InstituteOTHER | 1 | Jun 12, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT01225744 | Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy(eSCOUT) | completed | Phase 2 | 47 | The Christie NHS Foundation TrustOTHER | 1 | Jun 11, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Nov 11, 2014source: clinicaltrials